PROTAGENIC THERAPEUTICS INC (PTIX) Forecast, Price Target & Analyst Ratings
NASDAQ:PTIX • US74365N3017
0.74 USD
-0.56 (-43.08%)
At close: Jan 2, 2026
0.43 USD
-0.31 (-41.89%)
After Hours: 1/2/2026, 8:00:01 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PROTAGENIC THERAPEUTICS INC (PTIX).
Forecast Snapshot
Consensus Price Target
N/A
N/A
Next Earnings Forecast
Release DateMar 30, 2026
ChartMill Buy Consensus
82.86%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.74 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
PTIX was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about PTIX.
In the previous month the buy percentage consensus was at a similar level.
PTIX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-10-29 | Maxim Group | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 30, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | ||||||||||||
| EBITDA YoY % growth | -500K | -1.8M -260.00% | -1.8M | -2.4M -33.33% | -2.3M 4.17% | -2.1M 8.70% | -2.6M -23.81% | -4.1M -57.69% | -3.6M 12.20% | -4.499M -24.97% | -5.651M -25.60% | |
| EBIT YoY % growth | -500K | -1.8M -260.00% | -1.8M | -2.4M -33.33% | -2.3M 4.17% | -2.1M 8.70% | -2.6M -23.81% | -4.1M -57.69% | -3.6M 12.20% | -4.527M -25.75% | -5.701M -25.93% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
PROTAGENIC THERAPEUTICS INC / PTIX Forecast FAQ
When does PROTAGENIC THERAPEUTICS INC (PTIX) report earnings?
PROTAGENIC THERAPEUTICS INC (PTIX) will report earnings on 2026-03-30.
Can you provide the consensus rating for PROTAGENIC THERAPEUTICS INC stock?
The consensus rating for PROTAGENIC THERAPEUTICS INC (PTIX) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.